[
  {
    "ts": "2025-11-28T11:59:37+00:00",
    "headline": "Is Boston Scientific Stock Underperforming the Nasdaq?",
    "summary": "Boston Scientific has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.",
    "url": "https://www.barchart.com/story/news/36355682/is-boston-scientific-stock-underperforming-the-nasdaq",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "7260649a-b915-31ed-af33-f5dca2d499ea",
      "content": {
        "id": "7260649a-b915-31ed-af33-f5dca2d499ea",
        "contentType": "STORY",
        "title": "Is Boston Scientific Stock Underperforming the Nasdaq?",
        "description": "",
        "summary": "Boston Scientific has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.",
        "pubDate": "2025-11-28T11:59:37Z",
        "displayTime": "2025-11-28T11:59:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/cc7fea10836cbb33e9d71fc757ad596f",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "Boston Scientific Corp_ logo on iPad- by Kate Krav-Rude via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iNHGqEzP9kv0pZCfQQ3www--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/cc7fea10836cbb33e9d71fc757ad596f.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O8L4akWCYYcwtZPxuR8mCw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/cc7fea10836cbb33e9d71fc757ad596f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36355682/is-boston-scientific-stock-underperforming-the-nasdaq",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-stock-underperforming-nasdaq-115937311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-28T14:30:02+00:00",
    "headline": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?",
    "summary": "According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-buy-wall-143002320.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c074f315-f32f-3bba-a33f-a3a6ef0c4cab",
      "content": {
        "id": "c074f315-f32f-3bba-a33f-a3a6ef0c4cab",
        "contentType": "STORY",
        "title": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?",
        "description": "",
        "summary": "According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
        "pubDate": "2025-11-28T14:30:02Z",
        "displayTime": "2025-11-28T14:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a",
          "originalWidth": 900,
          "originalHeight": 476,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5btkEdScc6bMd.LwAmujVg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 900,
              "height": 476,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSL6wqVlNgtKuHixyahWwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-buy-wall-143002320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-buy-wall-143002320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-28T17:44:00+00:00",
    "headline": "Here's Why You Should Retain Glaukos Stock in Your Portfolio",
    "summary": "GKOS gains momentum from iDose TR's strong launch and a growing pipeline, though reimbursement hurdles pose challenges ahead.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-174400965.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a275bb0a-fd0e-3bcc-b3f5-392c7033680f",
      "content": {
        "id": "a275bb0a-fd0e-3bcc-b3f5-392c7033680f",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain Glaukos Stock in Your Portfolio",
        "description": "",
        "summary": "GKOS gains momentum from iDose TR's strong launch and a growing pipeline, though reimbursement hurdles pose challenges ahead.",
        "pubDate": "2025-11-28T17:44:00Z",
        "displayTime": "2025-11-28T17:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rWMhRFFPXvxgHEXE2B1wdA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7wTUD3ufBzPmxbF02fBrHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-174400965.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-174400965.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GKOS"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]